Clinical trial NCT00043576 - References

Prostate Cancer — ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Citation(s)

•   Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD
  Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol. 2003 Jan 1;21(1):123-8.
•   Beer TM, Munar M, Henner WD
  A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer. 2001 Jun 15;91(12):2431-9.
•   Beer, T
  M., Eilers, K.M., Garzotto, M., Lowe, B.A., Henner, W.D. Androgen-independent prostate cancer (AIPC) treatment with weekly high dose calcitriol and docetaxel. ASCO Abstract #707, v.21, p. 177a, 2002.

A Phase 2/3 Multicenter, Randomized, Double Blind Study of Docetaxel (Taxotere) Plus DN-101 or Placebo in Androgen Independent Prostate Cancer (AIPC)

Details for clinical trial NCT00043576